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ingly rare. This report documents a case of CXPA arising in the hard palate, which
showed transformation from pleomorphic adenoma (PA) to SCC reacted to Ki-67
immunostaining. Other immunohistochemical stains also demonstrated different
immunoreactivities between PA cells and SCC cells. Comparative genomic hybridiza-
tion identified a chromosomal imbalance. Gain regions of the PA were 8q11–22 and
8q24 and the loss region was 13q32–34 in PA; additionally, in SCC, regions charac-
terized by increased DNA copy number were 8p, 8q and 12q12–15.c 2005 Elsevier Ltd. All rights reserved.
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Carcinoma ex pleomorphic adenoma (CXPA) is a
rare malignant neoplasm of salivary gland account-
ing for approximately 2  5% of all pleomorphic
adenoma (PA).1 CXPA is the most frequently occur-
ring malignancy in the parotid gland; furthermore,
incidence in the minor salivary gland is very low.
The present report documents a rare example of
squamous cell carcinoma (SCC) ex pleomorphic
adenoma originating in palatal minor salivary
gland. Immunohistochemical staining and compara-
tive genomic hybridization (CGH) methodology
were employed to identify the tumor characteris-
tics and chromosomal imbalances. In addition, cor-
relation of chromosome copy number alterations
between CXPA and PA was discussed.Case report
A seventy two-year old man presenting with a
multi-year history of a mass on the left side of
the palate was referred to our facility. Physical
examination revealed an elastic-hard mass,
20 · 20 mm, with a 12 · 12 mm epithelial defect
(Fig. 1). Lymphadenopathy in the cervical region
was not palpable. Magnetic resonance imaging
scans disclosed a clearly definite mass in the palate
(Fig. 1). Initial pathological diagnosis by biopsy was
PA comprised of myoepithelial-type cells; evidence
of malignancy was not apparent. The tumor was re-
moved surgically with a sufficient safety margin;
subsequently, the resected tumor was examined
histologically in terms of finer detail. The majority
of the tumor consisted of myoepithelial-type andFigure 1 (Left) Gross appearance of tumor on the left si
resonance imaging scans indicating well-defined, heterogeneductal epithelial-type cells identical to those ob-
served in the biopsy sample; however, moderately
differentiated SCC located in the area of epithelial
defect was identified. These cells exhibited large
nuclei, prominent nucleoli and polygonal shape in
comparison with PA cells; moreover, myoepithe-
lial-type cells of PA clearly transformed to SCC
(Fig. 2). Immunohistochemical reaction for Ki-67
displayed positive readings in more than 40% of
SCC cells; in contrast, only 1% of PA cells were
stained. Finally, diagnosis of CXPA was rendered.
Additional immunohistochemical staining was
conducted. In the presence of keratin, SCC cells
were immunoreactive for AE1/AE3, whereas ductal
epithelial-type cells were positive for both AE1/
AE3 and CK7; myoepithelial-type cells were focally
positive. No cell type exhibited immunoreactivity
for CK20. SCC and ductal epithelial-type cells were
focally positive for EMA and CEA. Although PA con-
sisting of ductal epithelial-type and myoepithelial-
type cells was immunoreactive for S-100 protein,
SCC cells were not stained.
In order to examine the genetic relationship be-
tween SCC cells and myoepithelial-type cells, CGH
was conducted employing techniques described
previously.2,3 As a result, PA demonstrated in-
creased copy number at 8q11–12 and 8q24,
whereas SCC displayed increased copy number at
8p, 8q and 12q12–15. On the other hand, 13q32–
34 in PA and SCC was the common region of
decreased copy number (Table 1).Discussion
Numerous CXPA subtypes have been described
in previous reports.4,5 It appears that SCCde of the palate. (Right) Coronal T2-weighted magnetic
ous mass.
Figure 2 (Left) Squamous cell carcinoma (upper portion) and pleomorphic adenoma (lower portion) (H&E, ·40).
(Right) Transition from pleomorphic adenoma to squamous cell carcinoma. No border zone is present between these
neoplasms (·100).
Table 1 Immunohistochemical stain and CGH analysis
SCC PA
DEC MC
Immunohistochemical stain AE1/AE3 þ þ 
CK7  þ 
CK20   
EMA   
CEA   
Vimentin   
S-100   
Action   
GFAP   
c-erbB-2   
CGH Gain 8p 8q11–22
8q 8q24
12q12–15
Loss 13q32–34 13q32–34
SCC: squamous cell carcinoma cells, PA: pleomorphic adenoma, DEC: ductal epithelial-type cells, MC: myoepithelial-type cells
(þ): positive, (): partially positive, (): negative.
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and Gnepp.6 In differential diagnosis, it is impor-
tant to distinguish SCC and squamous cell metapla-
sia.7,8 In this case, squamous cell metaplasia was
suspected. Differential diagnosis was relativelyeasy, because cells positive for Ki-67 immunostain-
ing, a cell proliferation marker, were greater in the
SCC field than in the PA field. Zhu et al.9 indicated
that Ki-67 staining can discriminate between be-
nign and malignant tumors of parotid gland. Thus,
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tial diagnosis of SCC from squamous cell metapla-
gia in the current patient.
PA consisted of two components, ductal type
and myoepithelial type; moreover, based on histo-
logical findings, it appeared that SCC developed
from myoepithelial type. Ten kinds of immuno-
staining were performed according to the report
of Lewis et al.,10 which involved 69 instances of
CXPA in which SCC was not included. They noted
that more than 75% of CXPA specimens exhibited
positive staining for AE1/AE3, EMA and CEA. Inter-
estingly, CK7 and CK20 were positive in 94% and
13% of CXPA samples, respectively. In this case,
distinct reactions in AE1/AE3, CK7 EMA and CEA
staining were observed between ductal epithelial-
type and myoepithelial-type cells; as a result, in
all likelihood, the two cell types should display
different characteristics. SCC cells, ductal epithe-
lial-type cells and myoepithelial-type cells were
immunoreactive for AE1/AE3, which is a marker
of epithelial cells, indicating that these cells origi-
nated in epithelial cells. On the other hand, a pre-
vious report suggested that combination staining
with CK7 and CK20 is useful for determination of
the origin of adenocarcinoma;11 additionally, ade-
nocarcinoma demonstrated positive staining in
CK7 and negative staining in CK20. In this case,
ductal epithelial-type cells exhibited a positive
reaction for CK7; in contrast, SCC cells did not
react. These results suggest that SCC cells do not
possess characteristics identical to ductal epithe-
lial-type cells despite the fact that both cells dis-
played similar staining reactions, with the
exception of S-100.
CGH examination showed that chromosomal
alterations in chromosome 8 and 12 were related
to this tumor. While the gains in the 8q11–22 and
8q24 regions were detected in PA, important onco-
genes such as PLAG 1 and c-MYC may participate in
tumorigenesis.12 However, other oncogenes might
be involved in carcinogenesis, because copy num-
ber in the entire chromosome 8 increased in SCC.
With respect to the gain at 12q12–15, the proto-
oncogene HMGIC, MDM2, and CDK 4 located in
the12q14–15 region.13 Roijer et al.13 suggested
that amplification of these three genes may play
an important role in the malignant transformation
of benign PA. The gain region of 12q12–15 includes
12q14–15; consequently, their hypothesis may be
appropriate regarding development into CXPA.The loss region at 13q32–34 was evident in both
PA and SCC; however, tumor suppressor genes are
not located in this region to the best of our knowl-
edge. In summary, this investigation suggests that
copy number gains of the 8q11–22 and 8q24 re-
gions might be essential for development of PA.
In addition, the gain in the 12q12–15 region may
be required for progression from PA to SCC.References
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